EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis

James Kelly, Gavin Calpin, Robert Kelly, Mark Quinlan

Mesentery and Peritoneum · 2026-04 · 10 · AB016-AB016

DOI: 10.21037/map-26-ab016 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Mesentery and Peritoneum, 2026-04. Verfasst von James Kelly und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kelly, J., Calpin, G., Kelly, R., & Quinlan, M. (2026). AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis. Mesentery and Peritoneum, 10, AB016-AB016. https://doi.org/10.21037/map-26-ab016

Vancouver

Kelly J, Calpin G, Kelly R, Quinlan M. AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis. Mesentery and Peritoneum. 2026;10:AB016-AB016. doi:10.21037/map-26-ab016

BibTeX
@article{Kelly2026,
  author = {Kelly, James and Calpin, Gavin and Kelly, Robert and Quinlan, Mark},
  title = {AB016. SOH26AB_0294. The use of CT radiomics for predicting the malignant potential of residual retroperitoneal masses post-chemotherapy in metastatic testicular cancer: a systematic review and meta-analysis},
  journal = {Mesentery and Peritoneum},
  year = {2026},
  volume = {10},
  pages = {AB016--AB016},
  doi = {10.21037/map-26-ab016}
}
Kostenlos starten →